Paramiksovirüsler

Lamb RA, Parks GD. Paramyxoviridae: the viruses and their replication. In: Knipe DM, Howley PM (editors). Fields Virology. Philadelphia: Lippincott Williams and Wilkins; 2007. pp. 1449–1496.

Simmonds P, Adams MJ, Benkő M et al. Consensus statement: virus taxonomy in the age of metagenomics. Nature Reviews Microbiology. 2017; 15: 161–168.

Parks GD, Alexander-Miller MA. Paramyxovirus activation and inhibition of innate immune responses. Journal of Molecular Biology.2013;425(24):4872-4892. doi:10.1016/j.jmb.2013.09.015

Parks GD, Alexander-Miller MA. Paramyxovirus activation and inhibition of innate immune responses. Journal of Molecular Biology.2013 Dec 13;425(24):4872-92. doi: 10.1016/j.jmb.2013.09.015. Epub 2013 Sep 20. PMID: 24056173; PMCID: PMC3940258.

Khuri-Bulos N, Lawrence L, Piya B, Wang L, Fonnesbeck C, Faouri S, Shehabi A, Vermund SH, Williams JV, Halasa NB. Severe outcomes associated with respiratory viruses in newborns and infants: a prospective viral surveillance study in Jordan. British Medical Journal Open. 2018 May 20;8(5): e021898.

Tregoning JS, Schwarze J: Respiratory viral infections in infants: Causes, clinical symptoms, virology, and immunology. Clinical Microbiology Reviews.2010;23:74.

Beaird OE, Freifeld A, Ison MG, et al. Current practices for treatment of respiratory syncytial virus and other non-influenza respiratory viruses in high-risk patient populations: a survey of institutions in the Midwestern Respiratory Virus Collaborative. Transplant Infectious Disease 2016; 18:210.

Domachowske J, Halczyn J, Bonville CA. Preventing Pediatric Respiratory Syncytial Virus Infection. Pediatric Annals. 2018 Sep 01;47(9):e371-e376. [PubMed: 30208197]

Savic M, Penders Y, Shi T, et al. Respiratory syncytial virus disease burden in adults aged 60 years and older in high-income countries: A systematic literature review and meta-analysis. Influenza Other Respiratory Viruses. 2023; 17:e13031.

Mahony JB: Detection of respiratory viruses by molecular methods. Clinical Microbiology Reviews. 2008; 21: 716.

Ginocchio CC, McAdam AJ: Current best practices for respiratory virus testing. Journal of Clinical Microbiology. 2011;49:S44.

Langedijk A, Allicock O, Van Wijk M, et al. Saliva as an alternative to nasopharyngeal swabs for detection of respiratory syncytial virus (RSV) in children. European Respiratory Journal. 2022; 60:4519.

Griffiths C, Drews SJ, Marchant DJ. Respiratory Syncytial Virus: Infection, Detection, and New Options for Prevention and Treatment. Clinical Microbiology Reviews. 2017; 30:277.

Nam HH, Ison MG. Respiratory syncytial virus infection in adults. British Medical Journal. 2019; 366:l5021.

Foolad F, Aitken SL, Shigle TL, et al. Oral Versus Aerosolized Ribavirin for the Treatment of Respiratory Syncytial Virus Infections in Hematopoietic Cell Transplant Recipients. Clinical Infectious Disease. 2019; 68:1641.

French CE, McKenzie BC, Coope C, et al. Risk of nosocomial respiratory syncytial virus infection and effectiveness of control measures to prevent transmission events: a systematic review. Influenza and Other Respiratory Viruses. 2016; 10:268.

Schildgen V, van den Hoogen B, Fouchier R, et al: Human metapneumovirus: Lessons learned over the first decade. Clinical Microbiology Reviews. 2011;24:734.

Wang X, Li Y, Deloria-Knoll M, et al. Global burden of acute lower respiratory infection associated with human metapneumovirus in children under 5 years in 2018: a systematic review and modelling study. Lancet Glob Health 2021; 9:e33.

Papenburg J, Boivin G: The distinguishing features of human metapneumovirus and respiratory syncytial virus. Reviews in Medical Virology. 2010;20:245.

Edwards KM, Zhu Y, Griffin MR, et al. Burden of human metapneumovirus infection in young children. New England Journal of Medicine. 2013; 368:633.

Panda S, Mohakud NK, Pena L, et al. Human metapneumovirus: review of an important respiratory pathogen. International Journal of Infectious Disease. 2014; 25:45.

Wang X, Li Y, Deloria-Knoll M, et al. Global burden of acute lower respiratory infection associated with human parainfluenza virus in children younger than 5 years for 2018: a systematic review and meta-analysis. Lancet Glob Health. 2021; 9:e1077.

Pawełczyk M, Kowalski ML. The Role of Human Parainfluenza Virus Infections in the Immunopathology of the Respiratory Tract. Current Allergy and Asthma Reports. 2017; 17:16.

Schaap-Nutt A, Liesman R, Bartlett EJ, et al. Human parainfluenza virus serotypes differ in their kinetics of replication and cytokine secretion in human tracheobronchial airway epithelium. Virology 2012; 433:320.

Howard LM, Edwards KM, Zhu Y, et al. Parainfluenza Virus Types 1-3 Infections Among Children and Adults Hospitalized With Community-acquired Pneumonia. Clinical Infectious Disease 2021; 73:e4433.

Branche AR, Falsey AR. Parainfluenza Virus Infection. Seminars in Respiratory and Critical Care Medicine. 2016; 37:538.

Takamura S, Roberts AD, Jelley-Gibbs DM, et al. The route of priming influences the ability of respiratory virus-specific memory CD8+ T cells to be activated by residual antigen. Journal of Experimental and Clinical Medicine. 2010; 207:1153.

Self WH, Williams DJ, Zhu Y, et al. Respiratory Viral Detection in Children and Adults: Comparing Asymptomatic Controls and Patients With Community-Acquired Pneumonia. Journal of Infectious Disease. 2016; 213:584.

Waghmare A, Englund JA, Boeckh M. How I treat respiratory viral infections in the setting of intensive chemotherapy or hematopoietic cell transplantation. Blood. 2016; 127:2682.

Anderson LJ, Seward JF. Mumps epidemiology and immunity: the anatomy of a modern epidemic. Pediatric Infectious Disease Journal. 2008; 27:S75.

Clemmons NS, Redd SB, Gastañaduy PA, et al. Characteristics of Large Mumps Outbreaks in the United States, July 2010-December 2015. Clinical Infectious Disease. 2019; 68:1684.

Litman N, Baum SG. Mumps Virus. In: Principles and Practice of Infectious Diseases, Bennett JE, Dolin R, Blaser MJ (Eds), Churchill Livingstone, New York 2015.

Centers for Disease Control and Prevention. Mumps: Complications. https://www.cdc.gov/mumps/hcp.html#complications (Accessed on June 21, 2023).

Centers for Disease Control and Prevention. Manual for the Surveillance of Vaccine-Preventable Diseases. Chapter 9: Mumps. https://www.cdc.gov/vaccines/pubs/surv-manual/chpt09-mumps.html (Accessed on June 21, 2023).

Centers for Disease Control and Prevention. Mumps: Questions and Answers about Lab Testing. http://www.cdc.gov/mumps/lab/qa-lab-test-infect.html#st3 (Accessed on June 21, 2023).

World Health Organization. Guide for clinical case management and infection prevention and control during a measles outbreak https://apps.who.int/iris/handle/10665/331599 (Accessed on February 16, 2022).

Hübschen JM, Gouandjika-Vasilache I, Dina J. Measles. Lancet 2022; 399:678.

Bester JC. Measles and Measles Vaccination: A Review. Journal of American Medical Association Pediatr. 2016; 170:1209.

Bolotin S, Osman S, Hughes SL, et al. In Elimination Settings, Measles Antibodies Wane After Vaccination but Not After Infection: A Systematic Review and Meta-Analysis. Journal of Infectious Disease. 2022; 226:1127.

Campbell H, Lopez Bernal J, Bukasa A, et al. A Re-emergence of Subacute Sclerosing Panencephalitis in the United Kingdom. Pediatric Infectious Disease Journal. 2023; 42:82.

Zubach V, Beirnes J, Hayes S, et al. Diagnostic accuracy of commercially available serological tests for the detection of measles and rubella viruses: a systematic review and meta-analysis. Journal of Clinical Microbiology. 2024; 62:e0133923.

Gohil SK, Okubo S, Klish S, et al. Healthcare Workers and Post-Elimination Era Measles: Lessons on Acquisition and Exposure Prevention. Clinical Infectious Disease 2016; 62:166.

Clayton BA. Nipah virus: transmission of a zoonotic paramyxovirus. Current Opinion in Virology 2017; 22:97.

Field HE. Hendra virus ecology and transmission. Current Opinion in Virology 2016; 16:120.